Stock listing

Hanover:PHGN Pharming Group NV Aktie

German listing (Hanover) of Pharming Group NV · home listing Euronext:PHARM

Follow Pharming Group NV into a list and get an email when it puts out news.

Home listing price · EURONEXT:PHARM

€0.862 EUR +0.002 (+0.3%)

Close on Oct 15, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:PHARM

Pharming Group NV logo
Ticker
Hanover:PHGN
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Hanover
Currency
EUR

What changed lately

Calls

Replays

  • Pharming Group (Euronext:PHARM) Q2 2026 Earnings Call

    Thu, Jul 30, 2026 · 7:30 AM ET

    Watch Transcript

  • Pharming Group (Euronext:PHARM) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 7:30 AM ET

    Watch Transcript

  • Pharming Group (Euronext:PHARM) Q4 2025 Earnings Call

    Thu, Mar 12, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026

Oct 14, 2026

Pharming announces CEO transition

Sep 29, 2026

Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS

Sep 25, 2026

Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026

Sep 22, 2026

FDA approves Pharming's Joenja(R) as first treatment for children with APDS in the U.S.

Sep 14, 2026

FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.

Sep 11, 2026

Pharming Group to participate in September investor conferences

Sep 9, 2026

Pharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older

Aug 13, 2026

Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference

Aug 4, 2026

Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use

Jul 30, 2026

All Pharming Group NV news

Decks

Pharming Group NV on 6ix

Sector
Health care
Industry
Biotechnology
News releases
35 in the last 12 months · 52 in all · newest Oct 14, 2026 · oldest 2025
Calls
13 calls with a replay · 13 with a transcript · latest Jul 30, 2026
Decks
39 decks · latest September 2026

Where Pharming Group NV is listed

ListingExchangeCountryCurrency
Euronext:PHARM · Home listingEuronextNetherlandsEUR
NASDAQ:PHARNASDAQUnited StatesUSD
Aquis:PHARMAAquisUnited KingdomEUR
LSIN:0QCOLSINUnited KingdomEUR
gettex:PHGNgettexGermanyEUR
Aquis:PHARMAAquisUnited KingdomEUR
Tradegate:PHGNTradegateGermanyEUR
Xetra:PHGNXetraGermanyEUR
LS Exchange:A1H65ALS ExchangeGermanyEUR
OTC:PHGUFOTCUnited StatesUSD
BOATS:PHARBOATSUnited StatesUSD
Turquoise:PHARMATurquoiseUnited KingdomEUR
gettex:PHGgettexGermanyEUR
Lang & Schwarz:A1H65ALang & SchwarzGermanyEUR
Frankfurt:PHGNFrankfurtGermanyEUR
Hamburg:PHGNHamburgGermanyEUR
Stuttgart:PHGStuttgartGermanyEUR
BX Swiss:PHGNBX SwissSwitzerlandCHF
Dusseldorf:PHGNDusseldorfGermanyEUR
Frankfurt:PHGFrankfurtGermanyEUR
Lang & Schwarz:A2QLQYLang & SchwarzGermanyEUR
LS Exchange:A2QLQYLS ExchangeGermanyEUR
Munich:PHGNMunichGermanyEUR
Dusseldorf:PHGDusseldorfGermanyEUR
Munich:PHGMunichGermanyEUR
Stuttgart:PHGNStuttgartGermanyEUR
Hanover:PHGN · This pageHanoverGermanyEUR

Log in to ask 6ix AI your own questions about Pharming Group NV.